• Exchange: AktieTorget
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Respiratorius AB

+ Add to Watchlist

RESP:SS

0.4100 SEK 0.0200 4.65%

As of 12:00:02 ET on 07/25/2014.

Snapshot for Respiratorius AB (RESP)

Open: 0.4300 Day's Range: 0.4100 - 0.4400 Volume: 283,236
Previous Close: 0.4300 52wk Range: 0.2900 - 0.8900 1-Yr Rtn: +20.59%

Stock Chart for RESP

No chart data available.
  • RESP:SS 0.4100
  • 1D
  • 1M
  • 1Y
0.4300
Interactive RESP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RESP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -0.0480
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 49.90
Shares Outstanding (M) 121.71
30 Day Average Volume 194,287
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RESP

No data available

Company Profile & Key Executives for RESP

Respiratorius AB develops pharmaceutical drugs to treat Chronic Obstructive Pulmonary Disease (COPD) and asthma. The Company was founded in 1999 as a spin-off from Lund University.

Christer FahraeusChairman/Co-FounderMartin JohanssonHead:Medicinal Chemistry
More Company Profile & Key Executives for RESP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil